课题基金 / 基金详情

Role of actin-regulatory gelsolin in control of cell growth

Role of actin-regulatory gelsolin in control of cell growth
肌动蛋白调节凝溶胶蛋白在控制细胞生长中的作用
批准号:
06044009
负责人:
KUZUMAKI Noboru
金额:
$7.17万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

KUZUMAKI Noboru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. We cloned a mutant gelsolin cDNA His321 from the flat revertant R1 of human activated Ha-ras oncogene-transformed NIH3T3 fibroblasts (EJ-NIH3TS). His321 suppressed tumorigenicity of EJ-NIH3T3. We expressed the His321 and wild-type gelsolin in Escherichia coli, purified them, and analyzed their effects on actin, polyphosphoinositol lipids and phospholipase C.His321 decreased actin-filament-severing activity and increased nucleating activity compared with wild-type gelsolin in vitro. Furthermore, compared to wild-type gelsolin both nucleation and severing by His321 were inhibited more strongly by the phosphoinositol lipids phosphatidylinositol 4-phosphate (PtdInsP) and phosphatidylinositol 4,5-bisphosphate (PtdInsP2). In addition, His321 inhibited PtdInsP2 hydrolysis by phospholipase C gamma 1 more strongly than wild-type gelsolin in vitro because of its higher binding capacity for phosphoinositol Lipid. Our results suggest that the segment G3 of gelsolin which contains the mutation i … More s functionally relevant for regulation of gelsolin's activities and that the region around the residue 321 may contain a phosphoinositol-lipid-binding site. Altered functions of His321 gelsolin might be important for the loss of tumorigenicity of the ras-transformed cells.2. We examined the expression of gelsolin in a number of human bladder and colon cancer cell lines and tissues. In all 6 bladder and 6 of 7 colon cancer cell lines and in 14 of the 18 bladder(77.8%)and 9 of 18 colon(50%)tumor tissues, gelsolin expression was undetectable or extremely low in comparison with its expression in normal bladder or colon epithelial cells. Furthermore, upon the introduction of the exogenous human or mouse authentic gelsolin cDNA into a human bladder cancer cell line UMUC-2 or a human colon cancer cell line LoVo, gelsolin transfectants of UMUC-2 and LoVo greatly reduced the colony-forming ability and the tumorigenicity in vivo. These results suggest that gelsolin plays a key role as a tumor suppressor in human urinary bladder and colon carcinogenesis. Less
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Furuuchi, K.: "Growth inhibition of human colon carcinoma cells by gelsolin cDNA transfer." Tumor. Targeting.(in press).
Furuuchi, K.:“通过凝溶胶蛋白 cDNA 转移抑制人结肠癌细胞的生长。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishizaki, A.: "Growth inhibitory functions of a mutated gelsolin (His321) in NIH/3T3 mouse fibroblasts." Exp. Cell Res.217. 448-452 (1995)
Ishizaki, A.:“突变凝溶胶蛋白 (His321) 在 NIH/3T3 小鼠成纤维细胞中的生长抑制功能。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujita, H. ほか: "Enhanced inhibitory effect of the mutated gelsolin His321 on phospolipase Cγ_1." Cell Structure and Function. 18. 591 (1994)
Fujita, H. 等人:“突变凝溶胶蛋白 His321 对磷脂酶 Cγ_1 的增强抑制作用。细胞结构和功能”。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishizaki,A.ほか: "Growth inhibitory functions of a mutated gelsolin (His321) in NIH/3T3 mouse fibroblasts." Exp.Cell Res.217. 448-452 (1995)
Ishizaki, A. 等人:“突变凝溶胶蛋白 (His321) 在 NIH/3T3 小鼠成纤维细胞中的生长抑制功能。”Exp.Cell Res.217 (1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
15
    Prechnical research on gene therapy for oral cancer using a RAS dominant negative mutant
    • 批准号:
      14370651
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.58万
    • 财政年份:
      2002
    • 负责人:
      KUZUMAKI Noboru
    • 依托单位:
    Gene target therapy against human bladder cancer by gelsolin gene
    • 批准号:
      11557187
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $3.84万
    • 财政年份:
      1999
    • 负责人:
      KUZUMAKI Noboru
    • 依托单位:
    Clinical research of gene therapy against digestive tract cancers by using ras suppressor mutant.
    • 批准号:
      07557086
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $6.46万
    • 财政年份:
      1995
    • 负责人:
      KUZUMAKI Noboru
    • 依托单位:
    Tumor suppression by using gelsolin mutants
    • 批准号:
      07457546
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.93万
    • 财政年份:
      1995
    • 负责人:
      KUZUMAKI Noboru
    • 依托单位:
    国内基金
    海外基金
    ERα通过调节circ-SMG1.72/miR-141-3p/Gelsolin通路抑制肝癌细胞侵袭
    • 批准号:
      81903004
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.5万元
    • 批准年份:
      2019
    • 负责人:
      肖瑶
    • 依托单位:
    携Gelsolin单抗载紫杉醇靶向高分子超声微泡对肿瘤转移成像及抑制作用的研究
    • 批准号:
      81501476
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2015
    • 负责人:
      武俊
    • 依托单位:
    血浆型gelsolin(pGSN)在IgA肾病肾小球纤维化中的作用及机制
    • 批准号:
      81300584
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2013
    • 负责人:
      张磊
    • 依托单位:
    Gelsolin减轻辐射继发病理损伤作用和机制研究